Case History: A 62-year-old patient with a history of swelling on medial aspect of ankle for six months.
Case History: A 62-year-old patient with a history of swelling on medial aspect of ankle for six months.
[[{"type":"media","view_mode":"media_crop","fid":"18016","attributes":{"alt":"","class":"media-image","id":"media_crop_7317265512570","media_crop_h":"0","media_crop_image_style":"-1","media_crop_instance":"1205","media_crop_rotate":"0","media_crop_scale_h":"0","media_crop_scale_w":"0","media_crop_w":"0","media_crop_x":"0","media_crop_y":"0","title":" ","typeof":"foaf:Image"}}]]
Figures: 1 and 2: T2WI: Tumor is hypointense with few hyperintese cytic areas.
[[{"type":"media","view_mode":"media_crop","fid":"18030","attributes":{"alt":"","class":"media-image","id":"media_crop_5356072898986","media_crop_h":"0","media_crop_image_style":"-1","media_crop_instance":"1209","media_crop_rotate":"0","media_crop_scale_h":"0","media_crop_scale_w":"0","media_crop_w":"0","media_crop_x":"0","media_crop_y":"0","title":"","typeof":"foaf:Image"}}]]
Figure 2
[[{"type":"media","view_mode":"media_crop","fid":"18031","attributes":{"alt":"","class":"media-image","id":"media_crop_638940228687","media_crop_h":"0","media_crop_image_style":"-1","media_crop_instance":"1210","media_crop_rotate":"0","media_crop_scale_h":"0","media_crop_scale_w":"0","media_crop_w":"0","media_crop_x":"0","media_crop_y":"0","title":"","typeof":"foaf:Image"}}]]
Figures: 3 and 4: T1WI: Tumor is hypointense.
[[{"type":"media","view_mode":"media_crop","fid":"18032","attributes":{"alt":"","class":"media-image","id":"media_crop_942783655858","media_crop_h":"0","media_crop_image_style":"-1","media_crop_instance":"1211","media_crop_rotate":"0","media_crop_scale_h":"0","media_crop_scale_w":"0","media_crop_w":"0","media_crop_x":"0","media_crop_y":"0","title":"","typeof":"foaf:Image"}}]]
Figure 4
[[{"type":"media","view_mode":"media_crop","fid":"18033","attributes":{"alt":"","class":"media-image","id":"media_crop_3935036514741","media_crop_h":"0","media_crop_image_style":"-1","media_crop_instance":"1212","media_crop_rotate":"0","media_crop_scale_h":"0","media_crop_scale_w":"0","media_crop_w":"0","media_crop_x":"0","media_crop_y":"0","title":"","typeof":"foaf:Image"}}]]
Figures: 5, 6, and 7: FAT SAT STIR images: Tumor is not suppressed and appears slightly hyperintense
[[{"type":"media","view_mode":"media_crop","fid":"18034","attributes":{"alt":"","class":"media-image","id":"media_crop_4200214885084","media_crop_h":"0","media_crop_image_style":"-1","media_crop_instance":"1213","media_crop_rotate":"0","media_crop_scale_h":"0","media_crop_scale_w":"0","media_crop_w":"0","media_crop_x":"0","media_crop_y":"0","title":"","typeof":"foaf:Image"}}]]
Figure 6
[[{"type":"media","view_mode":"media_crop","fid":"18036","attributes":{"alt":"","class":"media-image","id":"media_crop_2283880546310","media_crop_h":"0","media_crop_image_style":"-1","media_crop_instance":"1215","media_crop_rotate":"0","media_crop_scale_h":"0","media_crop_scale_w":"0","media_crop_w":"0","media_crop_x":"0","media_crop_y":"0","title":"","typeof":"foaf:Image"}}]]
Figure 7
MRI reveals a large well defined altered signal intensity soft tissue mass lesion measuring about 56 x 54 x 50mm within sub-cutaneous planes posterior to talus and lateral to calcaneum. The lesion is appearing predominantly hypointesne on T1 and T2 images s/o solid part with few central cystic changes. The mass is extending into the tibio-talar and talo-calcaneal joint space.
Diagnosis: Spindle cell sarcoma
Discussion: Spindle cell sarcoma is a type of connective tissue cancer in which the cells are spindle-shaped when examined under a microscope. The tumors generally begin in layers of connective tissue such as that under the skin, between muscles, and surrounding organs, and will generally start as a small lump with inflammation that grows. At first the lump will be self-contained as the tumor exists in its stage 1 state, and will not necessarily expand beyond its encapsulated form.
However, it may develop cancerous processes that can only be detected through microscopic examination. As such, at this level the tumor is usually treated by excision that includes wide margins of healthy-looking tissue, followed by thorough biopsy and additional excision if necessary.
The prognosis for a stage 1 tumor excision is usually fairly positive, but if the tumors progress to levels 2 and 3, prognosis is worse because tumor cells have likely spread to other locations. These locations can either be nearby tissues or system-wide locations that include the lungs, kidneys, and liver. In these cases prognosis is grim and chemotherapy and radiation are the only methods of controlling the cancer.
Spindle cell sarcoma can develop for a variety of reasons, including genetic predisposition but it also may be caused by a combination of other factors including injury and inflammation in patients that are already thought to be predisposed to such tumors. Spindle cells are a naturally occurring part of the body's response to injury. In response to an injury, infection, or other immune response the connective tissues will begin dividing to heal the affected area, and if the tissue is predisposed to spindle cell cancer the high cellular turnover may result in a few becoming cancerous and forming a tumor.
Harpreet Singh, MD
JP Scan private diagnostic center, Khanna, Punjab, India
What a New Meta-Analysis Reveals About Fractional Flow Reserve Assessment with Computed Tomography
May 13th 2024While acknowledging variable accuracy overall with CT-derived fractional flow reserve (FFR-CT) values, researchers found that the accuracy rate increased to 90 percent for FFR-CT values greater > 0.90 and < 0.49.
Current Insights and Emerging Roles for Contrast-Enhanced Mammography
May 10th 2024In a recent lecture at the 2024 ARRS Annual Meeting, Jordana Phillips, MD, discussed the role of contrast-enhanced mammography in staging breast cancer, evaluating response to neoadjuvant chemotherapy and recalls from screening.
MRI-Based Deep Learning Algorithm Shows Comparable Detection of csPCa to Radiologists
May 8th 2024In a study involving over 1,000 visible prostate lesions on biparametric MRI, a deep learning algorithm detected 96 percent of clinically significant prostate cancer (csPCa) in comparison to a 98 percent detection rate for an expert genitourinary radiologist.